ABSTRACT. Polymorphisms of the major histocompatibility complex (MHC) have been linked to many diseases, especially autoimmune disorders. Previous studies have shown that genetic variants in MHC class III are associated with breast cancer. To determine if there is an association between MHC class III and breast cancer risk the Chinese Han population, we carried out a hospital based case-control study in a Chinese Han population in, including 216 histologically-confirmed breast cancer patients and 216 healthy controls. Nine SNP markers distributed in the class III coding region were detected using the Sequenom MassArray ® iPLEX System. Deviation from Hardy-Weinberg equilibrium was observed for seven SNPs. There was no significant association between these seven SNP variants and breast cancer in these Chinese women (unconditional logistic regression analysis). However, chr6_31697494 at BAT2, one of the seven SNPs, was found to be significantly associated with both ER-positive and PR-positive breast cancer. In addition, both chr6_31911109 at C6orf48 and chr6_31975605 at ZBTB12, another two of the seven SNPs, show relevance with ER-positive breast cancer. In conclusion, this is the first evidence that genetic polymorphisms in the MHC class III region are significantly associated with ER-positive breast cancer in Han Chinese population.
INTRODUCTION
Breast cancer is one of the most common fatal malignant diseases of women, where its incidence has been ranked number one (Jemal et al., 2011) . Compared to Western countries, breast cancer incidence is currently lower in China, but the rate of breast cancer in China is expected to increase substantially, from 10-60 cases per 100,000 women in 2008 to more than 100 cases per 100,000 women aged 55-69 years by 2021 (Linos et al., 2008; Ziegler et al., 2008) . Therefore, there is an urgent need to find key factors for breast cancer in Chinese women, and to take effective measures to control the incidence of breast cancer.
The major histocompatibility complex (MHC) is a group of genes with a high degree of polymorphism, and it is closely linked to a genomic region found in most vertebrates that is associated with reproduction and the immune system. The immune system is able to discriminate between normal and malignant tissues and to protect the host from tumor development by the recognition and subsequent elimination of aberrant cells (Dunn et al., 2002) . Failure of immune surveillance could lead to the formation of a tumor. Therefore, MHC plays an important role in antitumor immune response and immune surveillance through recruiting cytotoxic T lymphocytes against tumor antigens (Bhutia et al., 2010) .
A subset of the human MHC is human leukocyte antigen (HLA), which controls the antigen presenting system. HLA located on the short arm of chromosome 6, is a highly variable region, which mainly contains class I, class II and class III. Among these, class I molecules are found on all nucleated cells and present peptides to cytotoxic T cells. Class II molecules are found on certain immune cells and present tumor antigenic peptides on the cell surface to be recognized by T lymphocytes. Class III molecules are several secreted proteins with immune functions. It is clear that class III genes do not share the same function as class I and class II genes, but they are located between them in the short arm of human chromosome 6. For this reason they are frequently described together.
In recent years, a large number of data have been published on the role of MHC (also called HLA) class I and class II genes in recruiting of the cytotoxic T lymphocytes to mount a response against tumor antigens. However, there are few reports of HLA class III alleles in Chinese female population with breast cancer. Therefore, it is necessary to investigate whether HLA class III variants are associated with breast cancer susceptibility or prognostics in the Chinese Han population. In this study, we investigated 9 single nucleotide polymorphisms (SNPs) in the class III coding region in the Chinese Han population using the MassARRAY ® -IPLEX SNP genotyping. Although there were no statistical risk variants for breast cancer in the case-control study, the further study of positive or negative estrogen receptors revealed that C6orf48 chr6_31911109 and ZBTB12 chr6_31975605 variants were involved in good prognosis of breast cancer patients in Chinese Han population.
MATERIAL AND METHODS

Study population
Following pathology-based diagnoses, 216 patients with breast cancers were enrolled at the Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong Province, and at Huaian Maternal and Child Health Care Hospital of JiangSu Province, HuaiAn, P.R. China. The control group consisted of 216 subjects with no cancer of any type. The mean ages of the patients and the control subjects were 47.62 and 47.46 years, respectively. All subjects involved were Chinese Han women, and all subjects with clinical data provided informed consent before participating in the trial.
Additionally, the existence of estrogen and progesterone receptors in the tumor tissue was examined. The hormonal receptors of these tumors were distributed as follows: positive estrogen receptors (ER-positive) in 53 cases, negative estrogen receptors (ER-negative) in 136 cases, positive progesterone receptors (PR-positive) in 93 cases, and negative progesterone receptors (PR-negative) in 96 cases. In 27 cases, it was impossible to study both estrogen receptors and progesterone receptors.
Genotyping
Peripheral blood samples (5 mL) were collected after informed consent, and they were delivered and stored in a frozen state. Genomic DNA was extracted from 200 μL peripheral blood using a Genomic DNA Purification kit (Omega, China) according to manufacturer instructions and stored at -70°C until use. All of the SNPs were genotyped using SEQUENOM MassARRAY matrix-assisted laser desorption ionization-time of flight mass spectrometry platform (Sequenom, USA). Primers were designed using a semiautomated method (Assay Design 3.1, Sequenom). The call rate for each assay was set at >90%.
Statistical analysis
Hardy-Weinberg equilibrium (HWE) was examined using Haploview 4.1. Codominant, dominant, and recessive genetic models of inheritance were chosen to evaluate synthetically the associations between each SNP and breast cancer. We further divided the cases into different groups according to the status of estrogen or progesterone receptors. Association analysis based on unconditional logistic regression was carried out by calculating the odds ratio (OR) and 95% confidence interval (95%CI) for each SNP in the co-dominant and dominant genetic model; the significance level was set at P < 0.05. The statistical tests were implemented in the web-based tool SNPstats (http://bioinfo.iconcologia.net/SNPstats).
RESULTS
Of the 9 SNPs analyzed in the case-control study, 7 SNPs (chr6_31911109, chr6_31783744, chr6_32286548, chr6_31697494, chr6_31763660, chr6_31975605, chr6_32248546) conformed to Hardy-Weinberg proportions in the controls (P > 0.1; data not shown). The statistical analysis of only these 7 variants is outlined here, while statistical analysis data of the other variants are supplied as supplements. However, no statistically significant differences between the case and control groups were detected in the Han Chinese population (Table 1) .
In both ER and PR positive/negative groups (Table 2 and 3), chr6_31697494 in BAT2 showed a significant association with breast cancer, with zero CT genotyping in the ER and PR negative group. In the ER positive/negative study (Table 2) , chr6_31911109 in C6orf48 was linked to ER-positive breast cancer, with OR = 2.01 (95%CI = 1.02-3.96; P = 0.038). However, when evaluations were made for PR, there was a statistically insignificant correlation between C6orf48 and PR positivity in breast cancer (P = 0.2; Table 3 ). In addition, chr6_31975605 in ZBTB12 was found to confer a statistically significant correlation with ER-positive breast cancer, with OR = 2.19 (95%CI = 1.18-4.03; P = 0.011) and 0.95 (95%CI = 0.18-4.90; P = 0.019) for GC and GG, respectively (Table 2) . Also, chr6_31975605 showed a statistically insignificant association with PR-positive breast cancer (P = 0.58; Table 3 ). a
The corresponding odds radio (OR) is counted by age and gender adjustment. 95%CI = 95% confidence interval. The P value is counted by the web-based tool SNPstats. The corresponding odds ratio (OR) is counted by age and gender adjustment. 95%CI = confidence interval. b The P value is counted by the web-based tool SNPstats.
DISCUSSION
The MHC is located on the short arm of chromosome 6, with gene-dense spanning ~4 kb and encoding over 160 genes. Approximately 40% of these genes encode proteins involved in the immune system, including the HLA membrane glycoprotein that mediates T-lymphocyte signaling. Many diseases, including autoimmune, neurological, reproductive, endocrinological, and malignant disorders, have been found associated with MHC (Gruen and Weissman, 2001 ). Polymorphisms of HLA are connected with many diseases, especially autoimmune disorders (Shiina et al., 2004) . The human class III region, spanning approximately 700 kb, contains 61 genes and is the most gene-dense region of the human genome (Xie et al., 2003) . It is known for the complement component genes C4 factor B (BF) and C2, which encode subunit proteins for the C3 and C5 convertases, enzymes essential for the complement activation pathways of the humoral immune response (Yu, 1998; Milner and Campbell, 2001 ). This body of evidence indicates that genetic variants in the MHC class III region may be associated with malignant cancer.
Breast cancer is the most common malignancy among females worldwide. Several studies have investigated the association of the HLA class I and class II region in breast cancer in different ethnic groups and areas (Ghaderi et al., 2001; Lavado et al., 2005; Baccar et al., 2006; Cantú de León et al., 2009; Gun et al., 2012; Mahmoodi et al., 2012) . Attempts have also been made to reveal the relationship between the genes in the MHC class III region and mammary cancer. An earlier study carried out by Mestiri et al. (2001) found that genetic variation in TNF-αand hsp 70-2, which are the genes in the class III region, could increase risk of breast carcinoma and may predict clinical outcome. The entire HLA class III region was then researched by de Jong et al. (2003) , who suggested that HLA class III region may play a potential role in susceptibility to breast cancer in patients at moderate familial risk. In this study, we screened 9 SNPs in the MHC class III coding region, which are in the genes reported to be of relevance to the occurrence of cancer, to investigate the association between breast cancer and MHC class III in the Chinese Han population. However, no significant association between HLA class III variants and breast cancer was detected in this population.
Breast cancer patients with tumors that are ER-and/or PR-negative experience higher risks of mortality after their diagnosis compared to women with ER-and/or PR-positive disease (Anderson et al., 2001; Dunnwald et al., 2007) . An important implication of this is that variants determined in patients positive for these receptors could be related to good prognosis. In this study, we also stratified the analysis of the association between the 7 selected SNPs and ER-or PR-positive/negative breast cancer. The results showed that chr6 31697494 in BAT2 has a significant association with both ER-and PR-positive breast cancer. Furthermore, chr6_31911109 in C6orf48 and chr6_31975605 in ZBTB12 were found to be significantly correlated with ER-positive breast cancer.
The BAT2 gene (HLA-B-associated-transcript) of unknown function is located in the HLA class III region, and polymorphic microsatellites have been identified between the BAT2 gene and TNF gene (Spies et al., 1989; Iris et al., 1993) . This gene has microsatellite repeats which are associated with the age-at-onset of insulin-dependent diabetes mellitus (IDDM) and thought to be involved with the inflammatory process of pancreatic β-cell destruction during the development of IDDM (Hashimoto et al., 1999) . This gene is also a candidate gene for the development of rheumatoid arthritis (Singal et al., 2000) . Similarly, according to C6orf48 (chromosome 6 open reading frame 48) and ZBTB12 (zinc finger and BTB domain containing 12) are expressed in various tumor tissues. Nevertheless, no studies have investigated the effect of the three genetic polymorphisms on susceptibility for breast cancer. Data presented here demonstrate that chr6_31697494, chr6_31911109 and chr6_31975605 are significantly correlated to ER-or PR-positive breast cancer.
To sum up, the present study provides the first evidence that genetic polymorphisms in MHC class III region are insignificantly associated with breast cancer in our subjects. Further stratified analysis of the hormonal receptors showed a good prognosis in the chr6_31697494, chr6_31911109 and chr6_31975605 variations.
